JORGE CASTILLO to Biomarkers
This is a "connection" page, showing publications JORGE CASTILLO has written about Biomarkers.
Connection Strength
0.710
-
Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenstr?m macroglobulinaemia. Br J Haematol. 2019 03; 184(6):1011-1014.
Score: 0.077
-
Ibrutinib withdrawal symptoms in patients with Waldenstr?m macroglobulinemia. Haematologica. 2018 07; 103(7):e307-e310.
Score: 0.077
-
MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and?overall survival. Br J Haematol. 2018 02; 180(3):374-380.
Score: 0.076
-
IgM myeloma: A multicenter retrospective study of 134 patients. Am J Hematol. 2017 Aug; 92(8):746-751.
Score: 0.073
-
Idelalisib in Waldenstr?m macroglobulinemia: high incidence of hepatotoxicity. Leuk Lymphoma. 2017 04; 58(4):1002-1004.
Score: 0.070
-
Renal disease related to Waldenstr?m macroglobulinaemia: incidence, pathology and clinical outcomes. Br J Haematol. 2016 Nov; 175(4):623-630.
Score: 0.069
-
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. Leuk Lymphoma. 2016 09; 57(9):2071-6.
Score: 0.067
-
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma. Br J Haematol. 2015 May; 169(3):352-5.
Score: 0.062
-
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenstr?m macroglobulinemia. Blood Adv. 2024 04 09; 8(7):1639-1650.
Score: 0.029
-
High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy. Clin Lymphoma Myeloma Leuk. 2019 09; 19(9):e551-e557.
Score: 0.021
-
Progression Risk Stratification of Asymptomatic Waldenstr?m Macroglobulinemia. J Clin Oncol. 2019 06 01; 37(16):1403-1411.
Score: 0.021
-
Profiling of circulating exosomal miRNAs in patients with Waldenstr?m Macroglobulinemia. PLoS One. 2018; 13(10):e0204589.
Score: 0.020
-
Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome. Br J Haematol. 2017 10; 179(2):339-341.
Score: 0.017
-
The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma. 2016; 57(1):58-62.
Score: 0.016
-
Extranodal marginal zone lymphoma of the cranial dura mater: report of three cases and systematic review of the literature. Leuk Lymphoma. 2013 Oct; 54(10):2306-9.
Score: 0.014